The largest database of trusted experimental protocols

3 protocols using ifn γ

1

Differentiation of Naive CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen cells were excised from mice and single-cell suspensions of splenocytes were prepared in RPMI 1640 by teasing the organ through a sterile nylon mesh. Naive CD4+ T cells were purified using an EasySep mouse naive CD4+ T cell isolation kit (Stemcell Technologies, Vancouver, BC, Canada) and cultured with plate-bound anti-CD3 (5 µg/ml; Bio X Cell), anti-CD28 (5 µg/ml; Bio X Cell), and cytokines used alone, including IL-12 (R&D Systems), IFN-γ (R&D Systems), IL-1 (R&D Systems), IL-4 (R&D Systems), IL-6 (Cell Signaling Technology), IL-23 (eBioscience), and TGF-β (Invitrogen), or in combination with Abs (Bio X Cell) for Th17-promoting (2.5 ng/ml TGF-β, 20 ng/ml IL-6, 10 µg/ml anti–IFN-γ, 10 µg/ml anti–IL-4, 10 µg/ml anti–IL-2), Th1-promoting (10 ng/ml IL-12, 5 µg/ml anti–IL-4), Th2-promoting (10 ng/ml IL-4, 5 µg/ml anti–IFN-γ), or regulatory T cell (Treg)–promoting (5 ng/ml TGF-β, 5 µg/ml anti–IFN-γ, 5 µg/ml anti–IL-4) conditions. In some experiments, naive CD4+ T cells were cultured in Th17-promoting conditions and IL-21 (20 ng/ml; eBioscience) or IL-23 (50 ng/ml) was added to cultures after 24 h. Cells were harvested after 48 h for real-time PCR analysis and after 72 h for cytokine expression by flow cytometry as previously described (23 (link)).
+ Open protocol
+ Expand
2

Modulating Immune Responses with mAbs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected intraperitoneally (i.p) one day before infection with either 100 μg of mAb to NK1.1 (PK136, BioXcell) or 200 μg of mAb to IFN-γ (BioXcell) or its isotype control and the procedure was repeated twice a week until completion of the experiment and sacrifice of the mice. 2-DG (1g/kg, Sigma) was injected every other day starting from the day of infection and until completion of the experiment. For glucose supplementation, mice were treated with drinking water containing 30% (w/v) glucose (started 1 week before infection until sacrifice). To inducibly delete mTOR in Id2-expressing cells, Id2CreERT2 Rosa26tdRFP mice with or without mTOR flox/flox alleles (Id2iΔmTOR) received oral gavage of 5mg Tamoxifen in corn oil four times over the course of 10 days. One week later, mice subsequently received four doses of 100ng rIL-12 and rIL-18 intranasally over a 10-day period, following transient anesthesia with inhaled isoflurane, and were culled to harvest tissues one day after the final dose.
+ Open protocol
+ Expand
3

Antibody Modulation of Immune Checkpoints

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 mice were injected with following mAbs as indicated in figure legends: 250 μg/dose mouse IgG1 (Clone: MOPC-21; BioXcell), mouse IgG2a (Clone: C1.18.4), Rat-IgG2a (Clone: 2A3; BioXcell), of human CD28 domain specific antibody (100 μg/dose; Bristol-Myers Squibb), 250 μg/dose of anti-CD80 (Clone: 1G10; BioXcell), anti-CD86 (Clone: GL-1; BioXcell) CTLA4-Ig (Abatacept, Bristol-Myers Squibb), Anti-ICOS (Clone: 7E.17G9; BioXcell), Anti-CTLA4 (Clone UC10-4F10-11; Bio X Cell); Anti-PD1(Clone: 29F.1A12; BioXcell), TIM-3(Clone: RMT3.23; BioXcell), TIGIT (Clone:1G9; BioXcell), BTLA (Clone:6A6, BioXcell), VISTA(Clone: 13F3; BioXcell), CD70(Clone: FR70; BioXcell), CD48(Clone: HM48.1; BioXcell), TNF-α (Clone: XT3.11; BioXcell), IFNγ (Clone: XMG1.2; BioXcell), IFNAR (Clone:MAR1–5A3; BioXcell), IFNγR (Clone:GR20), IL-7 (Clone:M25; BioXcell), IL-7Rα (Clone:A7R34; BioXcell), CD40 (50 μg/dose; Clone:FGK4.5; BioXcell, CD40L (MR-1; BioXcell) Clone:, GITR (Clone:DTA-1; BioXcell), OX40 (Clone:OX-86; BioXcell), 4-1BB (Clone:LOB12.3; BioXcell), and Anti-MHC-I (500 μg/dose; Clone: M1/42; BioXcell).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!